<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01068067</url>
  </required_header>
  <id_info>
    <org_study_id>TAC+WUZHI</org_study_id>
    <nct_id>NCT01068067</nct_id>
  </id_info>
  <brief_title>Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients</brief_title>
  <official_title>Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Chinese Renal Transplant Recipients: A Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare pharmacogenetics plus drug combination (Schisandra
      sphenanthera extract,SchE)guided and standard initial tacrolimus dosage.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>C0 of tacrolimus after the initial dose, the percentage of out-of-range C0 after initial dose, the number of dose adjustments made to achieve therapeutic range (5-10 ng/ml) and the dose requirement to reach therapeutic range</measure>
    <time_frame>not less than three days after initial dose and not more than one month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>acute rejection rate within two weeks after transplantation</measure>
    <time_frame>within two weeks after transplantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum creatinine at fourteen days after transplantation</measure>
    <time_frame>fourteen days after transplantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Renal Transplantation</condition>
  <arm_group>
    <arm_group_label>pharmacogenetics plus SchE guided dosing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>standard dosing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>drug (tacrolimus and SchE) and genetics</intervention_name>
    <description>Patients were genotyped for the polymorphisms that can influence tacrolimus pharmacokinetics before transplantation. After transplantation, initial tacrolimus dosage was based on an algorism guided by pharmacogenetics and SchE.</description>
    <arm_group_label>pharmacogenetics plus SchE guided dosing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tacrolimus</intervention_name>
    <description>After transplantation, patients received standard initial dose of tacrolimus (0.050-0.075 mg/kg).</description>
    <arm_group_label>standard dosing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult (both males and females, 18-65 years) recipients underwent single primary renal
             transplantation in the First Affiliated Hospital of Sun Yat-sen University

          2. Wish to participate in the study

          3. Informed consent for the trial

        Exclusion Criteria:

          1. Patients with abnormal hepatic function, serious infection, malignant tumour, and
             diabetes mellitus

          2. Patients with ABO-incompatible renal transplantation

          3. Panel reactive antibody (PRA) levels greater than 30% before transplantation

          4. Underwent combined organ transplantations

          5. Except for SchE, other medication known to affect tacrolimus blood levels, such as
             diltiazem, verapamil, ketoconazole, itraconazole, erythromycin or clarithromycin was
             used

          6. Allergic history to study medicines

          7. During pregnancy or plan to get pregnant during the study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min Huang, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chang-Xi Wang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kidney Transplant Department, Transplant Center, the First Affiliated Hospital of Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jia-Li Li, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xue-Ding Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Si-Yang Chen, MM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesia Department, the First Affiliated Hospital of Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Min Huang, PhD</last_name>
    <phone>86-20-39943011</phone>
    <email>huangmin@mail.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Huang, PhD</last_name>
      <phone>86-20-39943011</phone>
      <email>huangmin@mail.sysu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Jia-Li Li, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xue-Ding Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kidney Transplant Department, Transplant Center, the First Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chang-Xi Wang, MD</last_name>
      <phone>86-20-87755766</phone>
      <phone_ext>813</phone_ext>
      <email>wcx6363@163.com</email>
    </contact>
    <investigator>
      <last_name>Qian Fu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Long-Shan Liu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://ghr.nlm.nih.gov/handbook</url>
    <description>Help Me Understand Genetics</description>
  </link>
  <link>
    <url>http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601117.html</url>
    <description>Tacrolimus</description>
  </link>
  <link>
    <url>http://en.wikipedia.org/wiki/Kidney_transplantation</url>
    <description>Kidney (Renal) transplantation</description>
  </link>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2010</study_first_submitted>
  <study_first_submitted_qc>February 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2010</study_first_posted>
  <last_update_submitted>July 26, 2010</last_update_submitted>
  <last_update_submitted_qc>July 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Min Huang</name_title>
    <organization>School of Pharmaceutical Sciences, Sun Yat-sen University</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

